UK funds gene-editing projects to combat climate-driven extinction
Biotech solutions aim to accelerate species adaptation amid rapid environmental changes
1Radical biotech interventions
The UK's Advanced Research and Invention Agency (Aria) is funding 14 projects totaling £54m to develop biotechnological tools for species conservation. These include gene-editing swallowtail butterflies for pesticide resistance and engineering oak trees to reproduce faster, enabling rapid adaptation to drought. The initiative represents a controversial shift from traditional conservation methods toward direct genetic intervention in wild species. Projects will operate under strict containment until 2030, with no field releases during testing phases.
2Precision conservation tools
Researchers compare these biotech approaches to mRNA vaccines for ecosystems, providing targeted solutions like bacterial shields against chytrid fungus killing amphibians. One project engineers skin bacteria to produce infection-blocking proteins for over 500 threatened amphibian species. Another develops RNA injections as 'vaccines' for ash trees against dieback fungus predicted to kill half of UK's ashes. The methods aim to complement rather than replace existing conservation strategies like protected reserves.
3Ethical governance framework
All projects must adhere to the IUCN's first global synthetic biology policy adopted in 2023, which survived a proposed ban backed by 90 NGOs. The policy establishes stringent criteria for biotech solutions after scientists demonstrated potential benefits, like eradicating invasive species on islands. Aria's ethical committee chair emphasizes secure lab containment until 2030, with no environmental releases during testing. Grantees must also obtain UK DEFRA approval for any future field deployments of genetically modified organisms.
4Political origins and scrutiny
Conceived by Dominic Cummings during Boris Johnson's administration, Aria faces criticism for funding US tech firms and its chair's resignation over conflicts with AI company Anthropic. The agency specializes in high-risk, high-reward projects, with £30m allocated initially and £24m reserved for successful initiatives. While aiming to restore UK's scientific leadership, the program's geoengineering research and taxpayer-funded grants to venture capital firms have drawn parliamentary concern about accountability and priorities.
5Species-specific interventions
University of Exeter researchers will CRISPR-edit swallowtail butterflies, an endangered UK species, to resist agricultural insecticides. Rothamsted Research accelerates oak reproduction cycles from decades to months for faster drought adaptation. Imperial College collaborates on engineering amphibian skin bacteria to combat chytrid fungus responsible for 90 extinctions. Cardiff University develops RNA injections to protect ash trees from dieback fungus, calling it 'arboreal vaccination'.
6Scientific skepticism remains
Evolutionary biologists caution that biotech solutions may have modest impacts and unpredictable ecosystem consequences. While chytrid fungus has caused mass amphibian die-offs, some species naturally develop resistance. Experts warn enhancing certain species could destabilize ecological balances, affecting non-target organisms. The Leverhulme Centre director notes these tools address symptoms rather than root causes like habitat destruction, calling over-optimism about preventing biodiversity loss 'naive' without systemic change.
7Implementation challenges
Beyond lab success, projects must clear regulatory hurdles including DEFRA's strict GMO release protocols. The two-year initial phase will assess feasibility before £24m in follow-on funding. Researchers acknowledge solutions may work only in localized contexts, like protecting specific ponds or woodlands. Political will and public acceptance remain uncertain for technologies that permanently alter species genetics. The program bets on a few 'world-changing' breakthroughs among many experiments.
8Broader conservation paradigm
This initiative reflects growing acknowledgment that traditional conservation cannot keep pace with climate change's rapid impacts. While reducing human environmental damage remains priority, scientists argue some ecosystems need emergency intervention. The projects test whether targeted biotech can buy time for species on the brink, though critics fear normalizing genetic manipulation of nature. Success could redefine 21st-century conservation strategies globally, especially for climate-vulnerable regions.